Immune tolerance therapy dose as an outcome predictor

Haemophilia

Volumn 9, Issue 4, 2003, Pages 382-386

  Dimichele, Donna ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Haemophilia A; Immune tolerance; Inhibitors

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR CONCENTRATE;

ARTICLE; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HEALTH CARE COST; HEMOPHILIA A; HEMOPHILIA B; HUMAN; IMMUNOLOGICAL TOLERANCE; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MORBIDITY; PREDICTION; PRIORITY JOURNAL; REIMBURSEMENT; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 0038148528     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00760.x     Document Type: Article

References (25)

1. Ehrenforth S, Kreutz W, Scharrer I et al. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-8.
2. Briet E, Reisner HM, Roberts HR. Inhibitors in Christmas disease. Prog Clin Biol Res 1984; 150: 123-9.
3. Aledort LM, Cohen M, Hilgartner M, Lipton R. Treatment of hemophiliacs with inhibitors: cost and effect on blood resources. Prog Clin Biol Res 1984; 150: 353-65.
4. Brackmann HH, Gormsen J. Massive factor VIII infusion in a haemophiliac with factor VIII inhibitor, high responder (letter). Lancet 1977; 2 (8044): 933.
5. Brackmann HH. Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol Res 1984; 150: 181-95.
6. Aznar JA, Jorquera JI, Peiro A et al. The importance of corticoids added to continued treatment with factor VIII concentrates in the suppression of inhibitors in hemophilia A. Thromb Haemost 1984; 51: 217-221.
7. Van Leeuwen EF, Mauser-Bunschoten EP, van Dijken PJ, Kok AJ, Sjamsvedin-Visset EJM, Sixma JJ. Disappearance of factor VIII. C antibodies in patients with haemophilia upon frequent administration of factor VIII in intermediate or low dose. Br J Haematol 1986; 64: 291-7.
8. Ewing NP, Sanders NL, Dietrich SL, Kasper CK. Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors. JAMA 1988; 259: 65-8.
9. Nilsson IM, Berntorp E, Zettervall O. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide and factor VIII. N Engl J Med 1988; 318: 947-50.
10. Gruppo RA, Valdez LP, Stout RD. Induction of immune tolerance in patients with hemophilia A and inhibitors. Am J Pediatr Hematol Oncol 1992; 14: 82-7.
11. Mauser-Bunschoten EP, Nieuwenhuis HK, Roosendaal G, van den Berg HM. Low dose immune tolerance induction in hemophilia A patients with inhibitors. Blood 1995; 86 (3): 983-8.
12. Kreuz W, Ehrenforth S, Funk M et al. Immune tolerance therapy in paediatric hemophiliacs with factor VIII inhibitors: 14 years follow up. Haemophilia 1995; 1: 24-32.
13. Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitors - twenty years' 'Bonn Protocol'. Vox Sang 1996; 70: 30-5.
14. Freiburghaus C, Berntorp E, Ekman M et al. Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995. Haemophilia 1998; 4: 16-20.
15. Freiburghaus C, Berntorp E, Ekman M et al. Tolerance induction using the Malmo treatment model 1982-95. Haemophilia 1999; 5: 32-9.
16. Oldenburg J, Schwaab R, Brackmann HH. Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn Protocol': Predictive parameter for therapy duration and outcome. Vox Sang 1999; 77 (1): 49-54.
17. Smith MP, Spence KJ, Waters EL et al. Immune Tolerance Therapy for Haemophilia A Patients with Acquired Factor VIII Alloantibodies: Comprehensive Analysis of Experience at a Single Institution. Thromb Haemost 1999; 81: 35-8.
18. Rocino A, de Biasi R. Successful Immune Tolerance Treatment with Monoclonal or Recombinant Factor VIII Concentrates in High Responding Inhibitor Patients. Vox Sang 1999; 77 (Suppl. 1): 65-9.
19. Nilsson IM, Berntorp E, Zetterval O. Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Pro Natl Acad Sci USA 1986; 83: 9169-73.
20. Mariani G, Ghirardini A, Bellocco R. Immune tolerance in hemophilia. Principal results from the international registry. Thromb Haemost 1994; 72 (1): 155-8.
21. Lenk H. and the Study Group of German Haemophilia Centres. The German Natl Immune Tolerance Registry, 1997 Update Vox Sang 1999; 77 (Suppl. 1): 28-30.
22. DiMichele DM, Kroner BL. and the North American Immune Tolerance Study Group. The North American Immune Tolerance Registry: Practices, Outcomes, Outcome Predictors. Thromb Haemost 2002; 87: 52-7.
23. Kroner B. Comparison of the International Immune Tolerance Registry and the North American Immune Tolerance Registry. Vox Sang 1999; 77 (1): 33-7.
24. Ewenstein BM, Takemoto C, Warrier I et al. Nephrotic Syndrome as a Complication of Immune Tolerance in Hemophilia B (letter). Blood 1997; 89 (3): 1115-6.
25. Colowick AB, Bohn RL, Avorn J et al. Immune Tolerance Induction in Hemophilia Patients with Inhibitors. Costly Can Be Cheaper Blood 2000; 96 (5): 1698-702.